By seeing the circumstances, we can say that Neuralink’s slow progress is becoming a major headache for Elon Musk, as he has reportedly made conversations with the experimental brain interface startup “Synchron” regarding investment in their business. The prevailing state of affairs might be the leading cause that compelled Musk to take this decision. However, both companies preferred to keep cards close to their chests as it’s still unclear whether Musk wants to invest in Synchron or is anticipating to indulge in some kind of collaboration. But the most intriguing aspect is that both companies are working on similar tech giants.
The founder of SpaceX and Neuralink, Elon Musk, is clearly not happy with the progress of Neuralink as things are not getting on the right track. You might be aware of how Synchron defeated Neuralink in the human trials and how the platform encountered strong skepticism after that. Not only this, the public has also charged Neuralink with brain-hacking monkeys by considering the system faulty. Also, the employees at Neuralink are not satisfied with working under the leadership of Musk, as they consider the working environment “chaotic and ineffective.”
Adding fuel to the fire, the co-founder of Neuralink also invested in Synchron this year, and this made the reputation of Neuralink more fragile in the market. As reported by Reuters, Musk has not pointed out any criticism toward employees of his company, nor did he mention anything about the sluggish growth of Neuralink. But the things that Musk discussed in the meeting with Synchron’s founder and chief executive, Thomas Oxley, are not yet disclosed.
However, if we talk about the functioning capability of Synchron’s chip, which was first embedded in a human being back in 2019, it demonstrates a different working than that of its competitor Neuralink. It has been seen that Synchron’s tech works by implanting the sensor in an artery rather than just implanting it in the skull like Neuralink. And Musk’s inclination towards Synchron seems a bit bizarre as it might shackle the working ideas of the two tech giants.
To that end, it is clear that Synchron has a strong market position as compared to Neuralink. Also, it should be noted that no real implants have been done on human beings by Neuralink, mainly because of the slow operations of the company. For now, we have to wait for the further proceedings regarding Musk’s investment in Synchrone and see how things will go in this domain.